SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-002930
Filing Date
2024-02-06
Accepted
2024-02-06 17:58:20
Documents
1
Period of Report
2024-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4072
  Complete submission text file 0001209191-24-002930.txt   5526
Mailing Address C/O DIAZ & ALTSCHUL CAPITAL 950 THIRD AVE NEW YORK NY 10022
Business Address
DIAZ REINALDO M (Reporting) CIK: 0001250086 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 24601485

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

IRS No.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)